We study how antibodies are generated in response to invading pathogens in mouse models, infected subjects and cancer patients. We use this information to produce novel antibodies for immunotherapy.

We aim to develop novel translational strategies that will improve immunity against cancer, and to optimize the potency of currently available antibody based immunotherapies

The interplay between viruses, cells, and the host's immune response.